SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : America On-Line (AOL)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ChinuSFO who wrote (16461)5/11/1999 8:59:00 AM
From: Glenn D. Rudolph  Read Replies (1) of 41369
 
NEW YORK, May 11 (Reuters) - Shares of Immunex Corp. rose
in pre-opening trade Tuesday after the drug company said it
would seek approval for expanded use of an arthritis drug.
Immunex was at 130 on the Instinet electronic broker
system, up from a Monday close at 107.
The rise came after the company said it planned to seek
regulatory approval for wider use of its drug Enbrel in
patients with early, active rheumatoid arthritis.
Among other active issues, America Online Inc. <AOL.N> rose
to 134-3/4 after the Web service provider said it had entered
four partnerships to develop its AOL TV product.
MORE
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext